FAQ

Dementia as a contemporary challenge for providing care for the aging populations

Data publikacji: 06.05.2019

Zdrowie Publiczne i Zarządzanie, 2019, Tom 17, Numer 1, s. 16-25

https://doi.org/10.4467/20842627OZ.19.003.11299

Autorzy

Alicja Klich-Rączka
Katedra Chorób Wewnętrznych i Gerontologii, Uniwersytet Jagielloński w Krakowie
https://orcid.org/0000-0002-9311-0078 Orcid
Kontakt z autorem
Wszystkie publikacje autora →

Tytuły

Dementia as a contemporary challenge for providing care for the aging populations

Abstrakt

Dementia occurs with a frequency of 10–12% in the entire geriatric population and 33–50% in people over 90 years of age. The most common cause of dementia are: Alzheimer’s disease, rarely vascular dementia, dementia with Lewy bodies, frontotemporal dementia and Parkinson’s disease with dementia. There are no medicaments to prevent dementia and effectively treat it. The treatment only slows the progression and improves the quality of life of the patient and caregiver. Taking care of a patient with dementia burdens the caregiver. As the disease progresses, care time extends even to the entire day. Over 90% of caregivers in Poland are family carers. Over 90% of patients stay in their own home until death. The cost of care is high and increases with the duration of the disease. In the case of agitated patients, the cost is higher. Institutional care is more expensive than home care. In Poland, there are no good system solutions in care for a dementia patient. Caregivers do not receive proper support from the government and subordinate units. 

Bibliografia

Pobierz bibliografię

Szukalski P., Decomposition of changes in life expectancy by age groups, Poland, 1950‒2008, “Przegl. Epidemiol.” 2010; 64 (3): 425‒430.

Piotrowicz K., Pac A., Skalska A.B., Chudek J., Klich­-Rączka A., Szybalska A., Michel J.P., Grodzicki T., Clustering of geriatric deficits emerges to be an essential feature of ageing ‒ results of a cross-sectional study in Po­land, “Aging (Albany NY)” 2016; 8 (10): 27.

Klich-Rączka A., Siuda J., Piotrowicz K., Boczarska-Jedy­nak M., Skalska A., Krzystanek E., Wizner B., Świat M., Skrzypek M., Opala G., Grodzicki T., Zaburzenia funkcji poznawczych u osób w starszym wieku, in: Mossakowska M., Więcek A., Błędowski P. (eds.), Aspekty medyczne, psy­chologiczne, socjologiczne i ekonomiczne starzenia się ludzi w Polsce, Termedia Wydawnictwa Medyczne, Poznań 2012.

Skalska A., Wizner B., Piotrowicz K., Klich-Rączka A., Klimek E., Mossakowska M., Rowiński R., Kozak-Szko­pek E., Jóźwiak A., Gąsowski J., Grodzicki T., The prev­alence of falls and their relation to visual and hearing impairments among a nation-wide cohort of older Poles, “Exp. Gerontol.” 2013; 48 (2): 140–146.

Diagnostyka i leczenie otępień. Rekomendacje zespołu eks­pertów Polskiego Towarzystwa Alzheimerowskiego, Wy­dawnictwo Medisfera, Otwock 2012.

Garre-Olmo J., Garcia-Ptacek S., Calvó-Perxas L., Tur­ró-Garriga O., López-Pousa S., Eriksdotter M., Diagnosis of dementia in the specialist setting: A comparison between the Swedish Dementia Registry (SveDem) and the Regis­try of Dementias of Girona (ReDeGi), “J. Alzheimers Dis.” 2016; 53 (4): 1341‒1345.

Mayeux R., Stern Y., Epidemiology of Alzheimer Disease, “Cold Spring Harb. Perspect. Med.” 2012; 2 (8): a006239.

Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie H., Huang Y., Jorm A., Mathers C., Menezes P.R., Rimmer E., Scazufca M., Alzheimer’s Disease International: Global prevalence of dementia: A Delphi consensus study, “Lancet” 2005; 366 (9503): 2112‒2117.

Klich-Rączka A., Piotrowicz K., Mossakowska M., Skals­ka A., Wizner B., Broczek K., Wieczorowska-Tobis K., Grodzicki T., The assessment of cognitive impairment suspected of dementia in Polish elderly people: Results of the population-based PolSenior Study, “Exp. Gerontol.” 2014; 57: 233‒242.

Langa K.M., Levine D.A., The diagnosis and management of mild cognitive impairment: a clinical review, “JAMA” 2014; 312 (23): 2551‒2561.

Petersen R.C., Lopez O., Armstrong M.J., Getchius T.S.D., Ganguli M., Gloss D., Gronseth G.S., Marson D., Pring­sheim T., Day G.S., Sager M., Stevens J., Rae-Grant A., Practice guideline update summary: Mild cognitive im­pairment: Report of the Guideline Development, Dissem­ination, and Implementation Subcommittee of the Ameri­can Academy of Neurology, “Neurology” 2018, 16; 90 (3): 126‒135.

Parnowski T., Szczudlik A., Sobów T., Gabryelewicz T., Zaburzenia neuropsychiatryczne w otępieniach. Uaktual­nione zasady terapii, Mediadore, Warszawa 2018.

Norton S., Matthews F.E., Barnes D.E., Yaffe K., Brayne C., Potential for primary prevention of Alzheimer’s dis­ease: An analysis of population-based data, “Lancet Neu­rol.” 2014; 13 (8): 788‒794.

Volkert D., Chourdakis M., Faxen-Irving G., Frühwald T., Landi F., Suominen M.H., Vandewoude M., Wirth R., Schneider S.M., ESPEN guidelines on nutrition in demen­tia, “Clin. Nutr.” 2015; 34 (6): 1052‒1073.

Park-Wyllie L.Y., Mamdani M.M., Li P., Gill S.S., Laupa­cis A., Juurlink D.N., Cholinesterase inhibitors and hos­pitalization for bradycardia: A population-based study, “PLoS Med.” 2009; 6 (9).

Pariente A., Sanctussy D.J., Miremont-Salamé G., Moore N., Haramburu F., Fourrier-Réglat A., L’Association Française des Centres Régionaux de Pharmacovigilance (CRPV): Factors associated with serious adverse reactions to cholinesterase inhibitors: a study of spontaneous report­ing, “CNS Drugs” 2010; 24 (1): 55‒63.

Little M.O., Updates in nutrition and polypharmacy, “Curr. Opin. Clin. Nutr. Metab. Care” 2018; 21 (1): 4‒9.

Soler A., Amer G., Leiva A., Ripoll J., Llorente M.A., Lei­va A., Taltavull J.M., Molina R., Llobera J., Continuation versus discontinuation of treatment for severe dementia: Randomized, pragmatic, open-label, clinical trial to evalu­ate the efficacy of continuing drug treatment in patients with severe dementia (STOP-DEM), “BMC Geriatr.” 2019; 19 (1): 101.

Kuo Y.C., Rajesh R., Challenges in the treatment of Alz­heimer’s disease: Recent progress and treatment strat­egies of pharmaceuticals targeting notable pathologi­cal factors, “Expert Rev. Neurother.” 2019 May 20. doi: 10.1080/14737175.2019.1621750. [Epub ahead of print].

Amjad H., David L., Roth D.L., Samus Q.M., Yasar S., Wolff J.L., Potentially unsafe activities and living condi­tions in older adults with dementia, “J. Am. Geriatr. Soc.” 2016; 64 (6): 1223–1232.

Sytuacja osób chorych na chorobę Alzheimera w Polsce. Raport RPO, Biuro Rzecznika Praw Obywatelskich, War­szawa 2016; https://www.rpo.gov.pl/sites/default/files/Sytu­acja%20osób%20chorych%20na%20chorobę%20Alzhei­mera%20wyd.II_.pdf (accessed: 02.04.2019).

Karczewska B., Bień B., Ołdak E., Jamiołkowski J., Opie­kunowie rodzinni osób starszych z otępieniem lub zaburze­niami poznawczymi w Polsce ‒ czynniki ryzyka obciążenia opieką, “Gerontologia Polska” 2012; 20: 2.

Black C.M., Ritchie C.W., Khandker R.K., Wood R., Jones E., Hu X., Ambegaonkar B.M., Non-professional caregiver burden is associated with the severity of patient’ cognitive impairment, “PLoS One” 2018; 13 (12).

Klich-Rączka A., Głaś M., Grodzicki T., Stan funkcji po­znawczych a zaniedbanie i samozaniedbanie, in: Tobiasz­-Adamczyk B., Brzyska M., Grodzicki T. (eds.), Zanie­dbanie i samozaniedbanie osób starszych. Medyczne i społeczne uwarunkowania, Ed. I, Wydawnictwo Uniwer­sytetu Jagiellońskiego, Kraków 2019: 105‒119.

Sutcliffe C., Giebel C., Bleijlevens M., Lethin C., Stolt M., Saks K., Soto M.E., Meyer G., Zabalegui A., Chester H., Challis D., on behalf of the RightTimePlaceCare Consortium, Caring for a person with dementia on the margins of long-term care: A perspective on Burden from 8 European coun­tries, “J. Am. Med. Dir. Assoc.” 2017; 18 (11): 967‒973.

Luengo-Fernandez R., Leal J., Gray A.M., UK research ex­penditure on dementia, heart disease, stroke and cancer: Are levels of spending related to disease burden? “Eur. J. Neurol.” 2012; 19 (1): 149‒154.

Cantarero-Prieto D., Leon P.L., Blazquez-Fernandez C., Juan P.S., Cobo C.S., The economic cost of dementia: A systematic review, “Dementia (London)” 2019; Mar 25: 1471301219837776 [Epub ahead of print].

Deb A., Thornton J.D., Sambamoorthi U., Innes K., Direct and indirect cost of managing alzheimer’s disease and re­lated dementias in the United States, “Expert. Rev. Phar­macoecon Outcomes Res.” 2017; 17 (2): 189‒202.

Wimo A., Reed C.C., Dodel R., Belger M., Jones R.W., Happich M., Argimon J.M., Bruno G., Novick D., Vellas B., Haro J.M., The GERAS Study: A prospective observa­tional study of costs and resource use in community dwell­ers with Alzheimer’s disease in three European countries ‒ study design and baseline findings, “J. Alzheimers Dis.” 2013; 36 (2): 385‒399.

Lenox-Smith A., Reed C., Lebrec J., Belger M.W., Re­source utilisation, costs and clinical outcomes in non-in­stitutionalised patients with Alzheimer’s disease: 18-month UK results from the GERAS observational study, “BMC Geriatr.” 2016; 16 (1): 195.

Olazarán J., Agüera-Ortiz L., Argimón J.M., Reed C., Ciudad A., Andrade P., Dilla T., Costs and quality of life in community-dwelling patients with Alzheimer’s disease in Spain: Results from the GERAS II observational study, “Int. Psychogeriatr.” 2017; 29 (12): 2081‒2093.

Bruno G., Mancini M., Bruti G., Dell’Agnello G., Reed C., Costs and resource use associated with Alzheimer’s dis­ease in Italy: Results from an observational study, “J. Prev. Alzheimers Dis.” 2018; 5 (1): 55‒64.

Belger M., Haro J.M., Reed C., Happich M., Argimon J.M., Bruno G., Dodel R., Jones R.W., Vellas B., Wimo A., Determinants of time to institutionalisation and relat­ed healthcare and societal costs in a community-based co­hort of patients with Alzheimer’s disease dementia, “Eur. J. Health Econ.” 2019; 20 (3): 343‒355.

Tucker S., Sutcliffe C., Bowns I., Challis D., Saks K., Ver­beek H., Cabrera E., Karlsson S., Leino-Kilpi H., Meyer G., Soto M.E., RightTimePlaceCare Consortium: Improv­ing the mix of institutional and community care for older people with dementia: An application of the balance of care approach in eight European countries, “Aging Ment. Health” 2016; 20 (12): 1327‒1338.

Wübker A., Zwakhalen S.M., Challis D., Suhonen R., Karlsson S., Zabalegui A., Soto M., Saks K., Sauerland D., Costs of care for people with dementia just before and after nursing home placement: primary data from eight Europe­an countries, “Eur. J. Health Econ.” 2015; 16 (7): 689‒707.

Schaller S., Mauskopf J., Kriza C.., Wahlster P, Kolomin­sky-Rabas P.L., The main cost drivers in dementia: a sys­tematic review, “Int. J. Geriatr. Psychiatry” 2015; 30 (2): 111‒129.

Livingston G., Barber J., Marston L., Stringer A., Panca M., Hunter R., Cooper C., Laybourne A., La Frenais F., Reeves S., Manela M., Lambe K., Banerjee S., Rapaport P., Clinical and cost-effectiveness of the Managing Agitation and Raising Quality of Life (MARQUE) intervention for agitation in people with dementia in care homes: A single-blind, cluster-randomised controlled trial, “Lancet Psychi­atry” 2019; 6 (4): 293‒304.

Panca M., Livingston G., Barber J., Cooper C., La Fre­nais F., Marston L., Cousins S., Hunter R.M., Healthcare resource utilisation and costs of agitation in people with dementia living in care homes in England ‒ The Manag­ing Agitation and Raising QUality of LifE in Dementia (MARQUE) study, “PLoS One” 2019; 14 (2): e0211953.

Costa N., Wübker A., De Mauléon A., Zwakhalen S.M.G., Challis D., Leino-Kilpi H., Hallberg I.R., Stephan A., Zabale­gui A., Saks K., Molinier L., Wimo A., Vellas B., Sauerland D., Binot I., Soto M.E., RightTimePlaceCare consortium costs of care of agitation associated with dementia in 8 Euro­pean countries: Results from the RightTimePlaceCare Study, “J. Am. Med. Dir. Assoc.” 2018;19 (1): 95.e1‒95.e10.

Durda M., Organizacja opieki nad ludźmi z demencją, “Gerontologia Polska”; 18 (2): 76–85.

Informacje

Informacje: Zdrowie Publiczne i Zarządzanie, 2019, Tom 17, Numer 1, s. 16-25

Typ artykułu: Oryginalny artykuł naukowy

Tytuły:

Angielski:

Dementia as a contemporary challenge for providing care for the aging populations

Autorzy

https://orcid.org/0000-0002-9311-0078

Alicja Klich-Rączka
Katedra Chorób Wewnętrznych i Gerontologii, Uniwersytet Jagielloński w Krakowie
https://orcid.org/0000-0002-9311-0078 Orcid
Kontakt z autorem
Wszystkie publikacje autora →

Katedra Chorób Wewnętrznych i Gerontologii, Uniwersytet Jagielloński w Krakowie

Publikacja: 06.05.2019

Status artykułu: Otwarte __T_UNLOCK

Licencja: CC BY-NC-ND  ikona licencji

Finansowanie artykułu:

Przygotowanie do wydania elektronicznego finansowane w ramach umowy 637/P-DUN/2019 ze środków Ministerstwa Nauki i Szkolnictwa Wyższego przeznaczonych na działalność upowszechniającą naukę.

Udział procentowy autorów:

Alicja Klich-Rączka (Autor) - 100%

Korekty artykułu:

-

Języki publikacji:

Angielski

Dementia as a contemporary challenge for providing care for the aging populations

cytuj

Pobierz PDF Pobierz

pobierz pliki

RIS BIB ENDNOTE